GRAM Adds Board Member
PTSM: Pharmaceutical Technology Sourcing and Management
Industry veteran Mark Kontny joins board of directors at Grand River Aseptic Manufacturing.
The Grand River Aseptic Manufacturing (GRAM) announced on Nov. 10 2015 that industry veteran Mark Kontny was elected as a member of the the board of directors.
Most recently, Kontny served as president, Pharmaceutical Development Services and chief scientific officer for Patheon. Previously, he served as divisional vice president for Abbott Laboratories, responsible for divisional staffs in Illinois, Massachusetts, Germany, and Singapore. Earlier in his career, Mark spent 10 years at Boehringer Ingelheim, working with the pre-formulation, formulation, and manufacturing of different dosage forms. He became senior director at Pfizer and helped develop small molecules and biologics in both solid-dose and parenteral forms. He worked with a biotech start-up, prior to joining Abbott.
Source: Grand River Aseptic Manufacturing
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
